Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AbbVie ends Phase III brain tumour study due to failed primary goal

pharmatimesMay 21, 2019

Tag: AbbVie , Phase III , brain tumour study

PharmaSources Customer Service